A
Absci Corporation (ABSI)
NMS – Real vaqt narxi. Valyuta: USD
10.89
+0.68 (6.66%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
10.98
+0.09 (0.83%)
Bozordan keyin: Jun 26, 2026, 7:59 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
10.89
+0.68 (6.66%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
10.98
+0.09 (0.83%)
Bozordan keyin: Jun 26, 2026, 7:59 PM EDT
Absci Corporation, klinik bosqichdagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda turli xil antiteloterapiya vositalarini ishlab chiqadi. Uning preklinik rivojlanish dasturlari orasida yallig'lanishli ichak kasalliklarini davolash uchun 1-faza klinik sinovlarida bo'lgan ABS-101; androgenetik alopetsiyani davolash uchun 1/2a faza klinik sinovlarida bo'lgan prolaktin retseptoriga (PRLR) qarshi antitelosi bo'lgan ABS-201; immüno-onkologiyani davolash uchun ABS-301; va onkologiyani davolash uchun ABS-501 mavjud. Absci Corporation qo'shma ilmiy-tadqiqot va ishlanmalar bo'yicha PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation va Advanced Micro Devices, Inc. bilan hamkorlik shartnomalariga ega. Kompaniya 2011-yilda tashkil etilgan va shtab-kvartirasi Vankuver, Vashingtonda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Christine Lemke D.V.M., M.B.A., Ph.D. | Senior Vice President of Portfolio & Growth Strategy |
| Dr. Ransi Somaratne FACC, M.B.A., M.D. | Chief Medical Officer |
| Dr. Zachariah Jonasson Ph.D. | Chief Business Officer & CFO |
| Mr. Alexander Khan CPA | CVP of Finance & Head of Investor Relations |
| Mr. Amer-Denis Akkad Ph.D. | Vice President of Research |
| Mr. Sean McClain | Founder, CEO, President & Director |
| Mr. Todd Bedrick CPA | Senior VP & Chief Accounting Officer |
| Mr. Wen Sha | Chief of Staff |
| Ms. Jeanne Schreuder M.B.A., SPHR | Senior Vice President of People & Experience |
| Ms. Shelby Walker J.D. | Chief Legal Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-24 | 8-K | d139233d8k.htm |
| 2026-06-05 | 8-K | absc-20260604.htm |
| 2026-05-07 | 8-K | absc-20260507.htm |
| 2026-05-07 | 10-Q | absi-20260331.htm |
| 2026-04-22 | DEFA14A | proxyadditionalmaterials20.htm |
| 2026-04-22 | DEF 14A | absi-20260422.htm |
| 2026-04-22 | ARS | a202510-kxasfiled.htm |
| 2026-03-24 | S-8 | s-8x2026x03x2026evergreeni.htm |
| 2026-03-24 | 8-K | absc-20260324.htm |
| 2026-03-06 | 8-K | absc-20260303.htm |